Staurosporine increases carcinoembryonic antigen expression in a human colon cancer cell line

Journal of Chemotherapy

Volumn 12, Issue 2, 2000, Pages 167-172

  Aquino, Angelo ^a   Prete, S P ^a   Baier, S ^a   Cappelletti, D ^a   Greiner, J W ^b   De Vecchis, L ^a   Graziani, G ^a   Bonmassar, E ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

CEA; Colon carcinoma; Immunotherapy; Staurosporine

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; STAUROSPORINE;

ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL POPULATION; COLON CARCINOMA; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG CARCINOMA;

EID: 0034009702     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2000.12.2.167     Document Type: Article

References (36)

1. 1 Maas IW, Boven E, Pinedo HM, Schluper HM, Haisma HJ. The effects of γ-interferon combined with 5-fluorouracil or 5-fluoro-2′-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines. Int J Cancer 1991; 48: 749-756.
2. 2 Guadagni F, Witt PL, Robbins PF, Schlom J, Greiner JW. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma. Cancer Res 1990; 50: 6248-6255.
3. 3 De Filippi R, Prete SP, Giuliani A, et al. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells. Anticancer Res 1994; 14: 1767-1773.
4. 4 Prete SP, Aquino A, Masci G, et al. Drug-induced changes of carcinoembryonic antigen expression in human cancer cells: effect of 5-fluorouracil. J Pharmacol Exp Ther 1996; 279: 1574-1581.
5. 5 Aquino A, Prete SP, Greiner JW, et al. Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells. Clin Cancer Res 1998; 4: 2473-2481.
6. 6 Liefers GJ, Cleton-Janes AM, Van de Velde CJH, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998; 339: 223-228.
7. 7 Castells A, Boix L, Bessa X, Gargallo L, Pique JM. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer 1998; 78: 1368-72.
8. 8 Greiner JW, Guadagni F, Noguchi P, et al. Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo. Science 1987; 235: 895-898.
9. 9 Greiner JW, Ullmann CD, Nieroda C, et al. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon. Cancer Res 1993; 53: 600-608.
10. 10 Tsanf KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst 1995; 87: 982-990.
11. 11 Cole DJ, Wilson MC, Baron PL, et al. Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge. Hum Gene Ther 1996; 7: 1381-1394.
12. 12 Foon KA, John WJ, Chakraborty M, et al. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. Clin Cancer Res 1997; 3: 1267-1276.
13. ++ dependent protein kinase. Biochem Biophys Res Commun 1986; 135; 397-402.
14. 14 Yoshizawa S, Fujiki H, Suguri H, et al. Tumor-promoting activity of staurosporine, a protein kinase inhibitor, in mouse skin. Cancer Res 1990; 50: 4974-4978.
15. 15 Courage C, Budworth J, Gescher A. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localization. Br J Cancer 1995; 71: 697-704.
16. 16 Chakrabarty S, Chen J W-J, Chen XYI. Modulation of differentiation-related responses in human colon carcinoma cells by protein kinase inhibitor H-7. Anticancer Res 1992; 12: 97-104.
17. 17 Yoshimura M, Nishikawa A, Nishiura T, et al. Cell spreading in Colo 201 by staurosporin is alpha 3 beta 1 integrin-mediated with tyrosine phosphorylation of src and tensin. J Biol Chem 1995; 270: 2298-2304.
18. 18 Yoshioka T, Masuko T, Kotanagi H, et al. Homotypic adhesion through carcinoembryonic antigen plays a role in hepatic metastasis development. Jpn J Cancer Res 1998; 89; 177-185.
19. 19 Babia T, Veldman RJ, Hoekstra D, KoK JW. Modulation of carcinoembryonic antigen release by glucosylceramide-implications for HT29 cell differentiation. Eur J Biochem 1998; 258: 233-242.
20. 20 Muraro R, Wonderlich D, Thor A, et al. Definition of monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res 1985; 45: 5769-5780.
21. 21 Gurley LR, Umbarger KO, Kim JM, Bradbury EM, Lehnert BE. High-performance liquid chromatographic analysis of staurosporine in vivo. Its traslocation and pharmacokinetics in rats. J Chromatogr B Biomed Sci Appl 1998; 712: 211-224.
22. 22 Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein Kinase C. Science 1992; 258: 607-614.
23. 23 Gescher A. Towards selective pharmacological modulation of protein kinase C - opportunities for the development of novel antineoplastic agents. Br J Cancer 1992; 66: 10-19.
24. 24 Akinaga S, Gomi K, Morimoto M, Tamaoki T, Okabe M. Antitumor Activity of UCN-01, a selective inhibitor of protein Kinase C, in murine and human tumor models. Cancer Res 1992; 51: 4888-4892.
25. 25 Begemann M, Kashimawo SA, Lunn RM, et al. Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase. Anticancer Res 1998; 18: 3139-3152.
26. 26 Nishi K, Schnier JB, Bradbury EM. The accumulation of cyclin-dependent kinase inhibitor p27kip1 is a primary response to staurosporine and independent of G1 cell cycle arrest. Exp Cell Res 1998; 243: 222-231
27. 27 Qiao L, Koutson M, Tsai L, et al. Staurosporine inhibits the proliferation, alters the cell cycle distribution and induces apoptosis in HT-29 human colon carcinoma cells. Cancer Lett 1996; 107: 83-89.
28. 28 Guadagni F, Witt PL, Robbins PF, Schlom J, Greiner JW. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma. Cancer Res 1990; 50: 6248-6255.
29. 29 Niles RM, Wilhem SA, Thomas P, Zamcheck N. The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation. Cancer Invest 1988; 6: 39-45.
30. 30 Wang H, Rajagopal S, Reynolds S, Cederberg H, Chakrabarty S. Differentiation-promoting effect of 1-O(2 methoxy) hexadecyl glycerol in human colon cancer cells. J Cell Physiol 1999; 178: 173-178.
31. 31 Yeatman TJ, Mao W, Karl RC. Biliary glycoprotein is overexpressed in human colon cancer cells with high metastatic potential. J Gastrointest Surg 1997; 1: 292-298.
32. 32 Chakrabarty S, Rajagopal S, Moskal TL. Protein kinase C alpha controls the adhesion but not the antiproliferative response of human colon carcinoma cells to transforming growth factor beta1: identification of two distinct branches of post-protein kinase C alpha adhesion signal pathway. Lab Invest 1998; 4: 413-421.
33. 33 Chakrabarty S, Huang S. Role of protein kinase C alpha in the induction of carcinoembryonic antigen by transforming growth factor beta 1. J Cell Phisiol 1995; 164: 148-153.
34. 34 Chakrabarty S. Role of protein kinase C in transforming factor beta 1 induction of carcinoembryonic antigen in human colon carcinoma cells. J Cell Phisiol 1992; 152: 494-499.
35. 35 Sausville EA, Lush RD, Headlee D, et al. Clinical pharmacology of UCN-01: initial observations and comparison to preclinical models. Cancer Chemother Pharmacol 1998; 42 (Suppl) S54-S59.
36. 36 Futamura M, Takagi Y, Koumura H, et al. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol 1998; 68: 34-40.